Clarithromycin description: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
| Line 21: | Line 19: | ||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} | ||
Revision as of 21:47, 8 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
References
Adapted from the FDA Package Insert.